EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The future of chemical pleurodesis: A review of novel and investigational sclerosant agents

Jonathan Glatt, Prarthna Chandar

The American Journal of the Medical Sciences · 2024-09 · 368 (3) · 175-181

DOI: 10.1016/j.amjms.2024.04.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The American Journal of the Medical Sciences, 2024-09. Verfasst von Jonathan Glatt und 1 weiteren Autor:innen. Beteiligte Einrichtung: Thomas Jefferson University Hospital, Department of Pulmonary, Allergy, and Critical Care Medicine, 834 Walnut Street, Suite 650, Philadelphia, PA 19…. Hauptthemen laut MEDLINE: Pleurodesis, Sclerosing Solutions. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemical pleurodesis is a technique in which an injurious and inflammatory substance is instilled into the pleural cavity to cause adhesion and fibrosis. It is commonly used in the management of recurrent malignant pleural effusions. Historically, many different types of sclerosants have been described, though only a few, including talc, the tetracycline derivatives, and anti-septic compounds such as silver nitrate and iodopovidone, have found their way into mainstream use. However, over the past several years, there has been increasing interest in alternative pleurodesis agents. In this review, we will explore future directions in the field, with an eye toward novel and investigational agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PleurodesisSclerosing SolutionsHumansPleural Effusion, MalignantTalc

Stichwörter der Autor:innen

Chemical pleurodesisExperimental treatmentsInvestigational treatmentsSclerosant agentTalc

Substanzen

Sclerosing SolutionsTalc

Autor:innen und Institutionen

  • Thomas Jefferson University Hospital, Department of Pulmonary, Allergy, and Critical Care Medicine, 834 Walnut Street, Suite 650, Philadelphia, PA 19107, USA. Electronic address: jglatt4@gmail.com.
  • Thomas Jefferson University Hospital, Department of Pulmonary, Allergy, and Critical Care Medicine, 834 Walnut Street, Suite 650, Philadelphia, PA 19107, USA.

Zitieren

APA

Glatt, J., & Chandar, P. (2024). The future of chemical pleurodesis: A review of novel and investigational sclerosant agents. The American Journal of the Medical Sciences, 368(3), 175-181. https://doi.org/10.1016/j.amjms.2024.04.008

Vancouver

Glatt J, Chandar P. The future of chemical pleurodesis: A review of novel and investigational sclerosant agents. The American Journal of the Medical Sciences. 2024;368(3):175-181. doi:10.1016/j.amjms.2024.04.008

BibTeX
@article{Glatt2024,
  author = {Glatt, Jonathan and Chandar, Prarthna},
  title = {The future of chemical pleurodesis: A review of novel and investigational sclerosant agents},
  journal = {The American Journal of the Medical Sciences},
  year = {2024},
  volume = {368},
  number = {3},
  pages = {175--181},
  doi = {10.1016/j.amjms.2024.04.008}
}
Kostenlos starten →